Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Tropical fish study offers insight into MS
Findings could have implications for human medicine

Insights gained from a study of tropical fish could improve our understanding of the nervous system, and even enhance the treatment of human conditions such as multiple sclerosis (MS).

By studying zebrafish, scientists at the University of Edinburgh uncovered vital clues about the production of myelin - a fatty sheath that insulates and protects the nerve fibres.

As myelin allows nerve impulses to be transmitted quickly, it is essential for good health. When it breaks down and is not repaired properly, it can lead to the debilitating symptoms of MS.

Zebrafish were used in the study as they share more than 80 per cent of the genes linked to human diseases, and exhibit very similar drug responses to humans. As young zebrafish are transparent, researchers were able to view their living nervous system without invasive surgery.

As a result of the study, scientists were able to quantify the time frame for developing myelin for the first time.

The findings demonstrate that the individual cells in the brain and central nervous system only have a matter of hours in which to generate the protective coating.

Following this, the team at Edinburgh are now investigating the ways in which gene manipulation and drugs could promote myelin generation in zebrafish.

Researcher at the university, Dr David Lyons, said: "To enhance myelin repair, we will need to improve either their ability to make myelin during the short time in which they have to do this, or find a way to allow them to produce myelin for a longer period of time."

The study, which has been published in Developmental Cell, offers hope for future treatments of myelin-related disorders in humans.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.